- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Projection of top 2018 pharma and biotech launches by revenue 2022
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Projection of top 2018 pharma and biotech launches by revenue 2022
Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
by Matej Mikulic,
last edited
Feb 18, 2019
This statistic depicts the top biotech and conventional pharmaceutical product launches globally in 2018 and their projected revenues for 2022. AbbVie's probably in 2018 to be-launched product Elagolix is expected to garner some 1.2 billion U.S. dollars in 2022.
Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
| Product (company) | Revenue in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Product (company) | Revenue in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Feb 18, 2019
This statistic depicts the top biotech and conventional pharmaceutical product launches globally in 2018 and their projected revenues for 2022. AbbVie's probably in 2018 to be-launched product Elagolix is expected to garner some 1.2 billion U.S. dollars in 2022.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- December 2017
- Region
- Worldwide
- Survey time period
- as of November 2017
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- December 2017
More information
- Region
- Worldwide
- Survey time period
- as of November 2017
Other statistics on the topic
Biotechnology industry
+Pharmaceutical Products & Market
2018 list of global top 10 biotech and pharmaceutical companies based on net income
+Pharmaceutical Products & Market
Total global pharmaceutical R&D spending 2010-2024
+Pharmaceutical Products & Market
World pharmaceutical sales 2016-2018 by region
+Pharmaceutical Products & Market
Top therapeutic classes by global pharmaceutical sales 2018 estimates
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Biotech industry
- 90 page/s
- English
- pptx
- Detailed references
Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Global pharmaceutical industry"
- Overview
The most important statistics
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)Pharmaceutical market: worldwide revenue 2001-2018
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by regionGlobal pharmaceutical market - revenue distribution 2010-2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Companies and products
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2018 list of global top 10 biotech and pharmaceutical companies based on net income
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018Top pharmaceutical companies by capex growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*Revenues of leading global generics manufacturers 2018
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2018
- Top companies by revenue
The most important statistics
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2018
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)Roche Group's total sales 2006-2018
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)Roche Group's total sales by division 2013-2018
- R&D, patents, new products
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*Patent expiration risks for total worldwide prescription drug revenue 2010-2024
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)Projected sales at risk due to patent expiry 2009-2022
- Number of new chemical or biological entities developed between 1992 and 2018, by region of originPharmaceutical industry - number of new substances 1992-2018
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Outlook
The most important statistics
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by countryPharmaceutical sector growth worldwide 2017-2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)Global spending on medicines 2010-2023
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)Country comparison in spending on medicine 2023
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)Leading global pharmaceutical products and respective revenues 2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Italy: number of biotech drugs marketed 2016-2017, by type
- Global pharmaceutical product launches by therapy area 2004-2013
- Projection of top 10 global pharmaceutical products by revenue 2019
- Top drugs based on projected 2019 year-on-year sales increase
- Italy: number of R&D employees of biotech pharma companies 2014-2017
- Italy: turnover of biotech drugs 2014-2017
- Italy: value of investments in R&D of biotech pharma companies 2014-2017
- Italy: number of biotech companies in the pharma sector 2014-2017
- Members of EFPIA's pharmaceutical exports and imports 1990-2018
- Count of first-time medtech approvals granted by FDA 2006-2017
- Italy: production value of pharmaceutical companies 2015-2017
- Global pharmaceutical gross value added by product type 2012
- Share of global pharmaceutical gross value added by product type 2012
- Global jet lag therapy market size by 2016 and 2023
- Austria: medicament mixtures not in dosage export value 2012-2018
- Industry revenue of »manufacture of basic pharmaceutical products« in Spain 2011-2023
- Poland: pharmaceutical goods import value 2012-2018
- Industry revenue of »manufacture of optical and photographic equipment« in Hungary 2011-20...
Studies
- Biotechnology in Germany
- Value and Innovation Framework Report 2019
- LEO Pharma A/S Annual Report 2017
- Sobi Anual and sustainability report 2017
- Indicatori Farmaceutici
- Novo Nordisk ANNUAL REPORT 2017
- Pharmaceutical industry in Italy
- Celgene Corporation - 2018 Form 10-K
- Medtronic - 2019 Form 10-K
- Pharmaceutical trends in Europe
- Biogen Inc. - 2018 Form 10-K
- Gilead Sciences - 2018 Form 10-K
- Dechra Pharmaceuticals PLC Annual Report 2018
- Lundbeck Annual Report 2017
- The Changing Face of Global Clinical Trials
Statistics on "Global pharmaceutical industry"
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)
- Number of new chemical or biological entities developed between 1992 and 2018, by region of origin
- Total number of novel drugs approved by CDER from 2008 to 2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019 (in million U.S. dollars)
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
- Number of biotech orphan drugs marketed in Italy between 2016 and 2017, by type (in units)
- Number of biotech projects along the drug pipeline in Italy between 2016 and 2017, by therapeutic area
- Number of biotech drugs marketed in Italy between 2016 and 2017, by type (in units)
- Global pharmaceutical product launches between 2004 and 2013, by therapy area*
- Projected top 10 pharmaceutical products worldwide by revenue in 2019 (in billion U.S. dollars)
- Top drugs based on projected 2019 year-on-year sales increase (in billion U.S. dollars)
- Number of R&D employees of biotech pharmaceutical companies in Italy in selected years from 2014 to 2017
- Turnover of biotech companies operating in the pharmaceutical sector in Italy in selected years from 2014 to 2017 (in billion euros)
- Value of investments in R&D of biotech pharmaceutical companies in Italy in selected years from 2014 to 2017 (in million euros)
- Number of biotech companies in the pharmaceutical sector in Italy in selected years from 2014 to 2017
- Pharmaceutical imports and exports of EFPIA members from 1990 to 2018 (in million euros)
- Number of medtech first-time approvals (PMA/HDE/PDP) granted by the FDA per year from 2006 to 2017*
- Production value of pharmaceutical companies* in Italy from 2015 to 2017 (in million euros)
- Global pharmaceutical gross value added in 2012, by product type (in billion U.S. dollars)
- Percentage of global pharmaceutical gross value added in 2012, by product type
- Global jet lag therapy market size in 2016 and a forecast for 2023 (in million U.S. dollars)*
- Value of medicament mixtures not in dosage exported from Austria from 2012 to 2018 (in 1,000 euros)
- Industry revenue of »manufacture of basic pharmaceutical products« in Spain from 2011 to 2023 (in million U.S. Dollars)
- Value of pharmaceutical goods imported to Poland from 2012 to 2018 (in 1,000 euro)
- Industry revenue of »manufacture of optical and photographic equipment« in Hungary from 2011 to 2023 (in million U.S. Dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.